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Case report
A 23-year-old G2P1 woman in her 27th week of  preg-
nancy presented with gradual onset of  left anteromedial 
tibial pain and swelling for one month. She was evaluated 
by an orthopedist after she left her car out of  gear and at-
tempted to stop the car with her left leg. On radiographs, 
no fractures were present, but a lytic lesion of  the left 
proximal tibia was noted. She was referred to the sarcoma 
clinic for further evaluation. On interview, she complained 
of  fatigue, weakness, fevers, and night sweats for the past 
two weeks. Past medical history and review of  systems were 
noncontributory. On examination, the patient was found to 
have an exquisitely tender 1-cm to 1.5-cm warm, nonery-
thematous mass overlying the left proximal anteromedial 
tibia. Range of  motion, strength, and sensation of  the 
lower extremity were intact. The remainder of  the physical 
exam was normal.
Imaging was reviewed. AP and lateral radiographs of  the 
tibia and fibula revealed an ill-defined, oval, lucent lesion in 
the anterior tibial tubercle measuring 2.2 x 1.1 x 1.0 cm 
(Fig. 1). MRI of  the knee (axial T2 FS, sagittal proton den-
sity with contrast, and sagittal T2 FS views) showed a lesion 
in the medial aspect of  the anterior tibial tubercle. The 
intraosseous portion showed multilocular fluid-fluid levels. 
A 10-mm defect in the overlying anteromedial cortex ap-
peared with an exophytic component of  tumor extending 
into the soft tissue, measuring 1.7 cm in greatest dimension.  
There was no periosteal or endosteal reactive bone. A small 
amount of  secondary marrow and soft-tissue edema was 
present (Fig. 2A-C).
Aggressive features of  the lesion requiring tissue diagno-
sis to exclude malignancy included destruction with cortical 
breakthrough, soft-tissue mass, and lack of  reactive bone 
formation. The lesion’s location, unifocality, size, defined 
anterior border with soft-tissue displacement rather than 
infiltration, and lack of  periosteal reaction were all impor-
tant factors in narrowing the radiographic differential diag-
nosis. Based on the lesion’s radiographic appearance, a 
revised differential diagnosis included giant-cell tumor 
(GCT), aneurysmal bone cyst, chondrosarcoma, chondro-
myxoid fibroma, periosteal sarcoma, and lytic metastasis.
The patient underwent surgical removal of  the mass with 
curettage, sparing of  the infrapatellar nerve, and recon-
struction with bone grafting. Frozen sections of  the lesion 
revealed a giant-cell-rich tumor with a fairly diffuse distri-
bution of  giant cells favoring GCT or possibly aneurysmal 
bone cyst. On formalin-fixed permanent sections, the tu-
mor was remarkable for sheets and lobules of  giant cells 
admixed with mononuclear histiocytic- and fibroblastic-
appearing cells (Fig. 3). In some areas, giant-cell reparative 
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Figure 1. 23-year-old woman with giant-cell tumor. A. AP radiograph shows an ill-defined, oval, lucent lesion in the proximal 
tibial metaphysis. B. Lateral radiograph shows that the lesion is located in the anterior tibial tubercle.
Figure 2. 23-year-old woman with giant-cell tumor. A. Axial T2 FS shows a lesion in the medial aspect of the anterior tibial tu-
bercle. The intraosseous portion shows multilocular fluid-fluid levels. There is a 10-mm hole in the overlying anteromedial cor-
tex with an exophytic component of tumor extending into the soft tissues, measuring 1.7 cm in greatest dimension. There is no 
periosteal or endosteal reactive bone. A small amount of surrounding marrow and soft-tissue edema is present. B. Sagittal SE 
TE:24 TR:2300 + contrast MRI. C. Sagittal T2 FS MRI.
 
granuloma-like features appeared, including a prominent 
fibroblastic population and more lobulated architecture. In 
other regions, a more polygonal- to histiocytic-appearing 
mononuclear population appeared among sheets of  giant 
cells with similar-appearing nuclei and a syncytial distribu-
tion—such that the giant cells and mononuclear cells were 
difficult to distinguish from each other. The latter areas 
were diagnostic of  GCT of  bone. Hemorrhage and focal 
cystic changes were also noted, corresponding to the fluid-
fluid levels seen on imaging. Reparative granuloma-like 
features were seen as a secondary phenomenon in benign 
bone tumors, including GCT. Although the radiologic find-
ings in this patient were not classic for GCT of  bone, the 
histopathological findings supported classification as GCT. 
On three-month followup, the patient had given birth to 
her child in the interval. She complained of  mild to moder-
ate pain in the distribution of  the infrapatellar nerve but 
was otherwise asymptomatic. She was without evidence of  
locally recurrent tumor on physical exam as well as three-
view radiography of  the tibia and fibula. Chest radiography 
showed no evidence of  pulmonary metastasis.
Discussion
GCT of  the bone is a common benign bone tumor, ac-
counting for 6.6% of  bone tumors and 21.87% of  benign 
bone tumors in a large Mayo Clinic series (1). Pathologi-
cally, GCT is characterized by the presence of  many multi-
nucleated giant cells evenly spread throughout a field of  
mononuclear stromal cells (2). GCT of  bone has slightly 
increased incidence in women (50.7 to 57% of  cases) (1, 3-
5). It arises most frequently in the third through fifth decade 
of  life (1, 4) and is relatively rare in children and adoles-
cents prior to epiphyseal closure (1, 4, 6). 
Radiographically, GCT of  bone typically appears as an 
eccentrically located lytic lesion associated with cortical 
thinning and bone expansion, most commonly arising in 
the epimetaphyseal region of  long bone. Protrusion 
through the cortex and extension into the adjacent soft tis-
sues may also occur (2). MRI can further elucidate the soft-
tissue findings in GCT of  bone. MRI of  GCT of  bone 
typically shows solid components with low to intermediate 
signal intensity at T1- and T2-weighted imaging. Fluid 
components may also be present, with low signal at T1 and 
high signal at T2. Aneurysmal bone-cyst changes are com-
monly found within GCT lesions and may have fluid-fluid 
levels (1, 2). Our patient’s lesion is atypical for GCT in that 
cortical thinning and bone expansion are not prominent; 
rather, penetration of  the cortex appears to have occurred 
in the absence of  cortical thinning. This exophytic mor-
phology may be related to the lesion’s uncharacteristic loca-
tion at the tibial tubercle.
GCT of  bone is nearly universally located at the epiphy-
sis and is thought to arise from the metaphyseal aspect of  
the epiphyseal plate (2). Rare examples of  metaphyseal and 
diaphyseal GCT have been described, with reported inci-
dence of  nonepiphyseal GCT of  only 0.8% in one large 
case review (7). The most common location is around the 
knee joint, with the distal femur and proximal tibia ac-
counting for 26% to 32% and 18% to 28% of  cases, re-
spectively (1, 3-5). GCT lesions are typically peri-articular, 
with subchondral location a major criterion for the diagno-
sis of  GCT (8). However, GCT has also been shown to oc-
cur at apophyses such as the patella and the greater tro-
chanter, which can be considered epiphyseal equivalents 
(1, 9). 
Our patient’s lesion’s location at the tibial tubercle is un-
usual and led to misidentification as a metaphyseal lesion at 
initial review of  the radiographs. In one case series (n = 
1682), four cases of  GCT involved the tibial tubercle and 
had been erroneously described as metaphyseal in location 
(7). Importantly, the tibial tubercle is a projection of  the 
proximal tibial epiphysis with its own ossification center, 
which closes in adolescence (10). As such, it can be re-
garded as an epiphyseal equivalent for bone tumor 
formation.
The role of  our patient’s pregnancy in the pathophysiol-
ogy of  her GCT is unclear. There are several case reports 
of  GCT of  bone incidence or recurrence in pregnancy (11,  
12, 13). Progesterone receptors have been described in 
GCT of  bone, but a clear functional effect has not been 
demonstrated (14, 15). On the other hand, estrogen recep-
tors have been identified and shown to have a slight anti-
apoptotic effect in one mononuclear cell population derived 
from a GCT (15). The presence of  increased mitotic figures 
in GCT in women who are pregnant or using hormonal 
contraception has also been anecdotally described (2). Con-
versely, estrogen has a well-established pro-apoptotic effect 
on osteoclasts (16), and an anti-osteolytic effect of  estrogen 
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Figure 3. 23-year-old woman with giant-cell tumor. Light 
microscopy of formalin-fixed permanent section reveals a 
polygonal- to histiocytic-appearing mononuclear population 
among sheets of giant cells with similar appearing nuclei 
and a syncytial distribution, such that the giant cells and 
mononuclear cells are difficult to distinguish from each 
other.
on the osteoclast-like multinucleated giant cells derived 
from GCT of  bone has been demonstrated (17). The 
osteoclast-like activity of  multinucleated giant cells is 
thought to be a mechanism of  tumor growth, and a mono-
clonal antibody against RANKL (an osteoclast activating 
ligand) is a promising therapy for inoperable GCT of  bone 
(18). Based on this evidence, estrogen could both promote 
and inhibit GCT tumor growth through differential action 
on two cell types, and further investigation on this topic is 
warranted. Finally, it is important to remember that the 
peak incidence of  GCT coincides with the peak incidence 
of  pregnancy, which may lead to coincidental occurrence.
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